CurrentRheuma coverage · page 36 of 48
Rheumatology (Oxford)
Latest from Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Pregnancy outcomes in patients with familial Mediterranean fever: systematic review and meta-analysis
Meta-analysisAutoinflammatory & rare
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Heart valve disease in primary antiphospholipid syndrome
Cohort studyLupus & APS
Rheumatology (Oxford)
Comparison of two frailty definitions in women with systemic lupus erythematosus
Cross-sectional studyLupus & APS
Rheumatology (Oxford)
Diffusion-weighted magnetic resonance imaging for the diagnosis of giant cell arteritis: a comparison with T1-weighted black-blood imaging
Diagnostic or prognostic studyVasculitis & PMR
Rheumatology (Oxford)
Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis: an open-label study
Randomized controlled trialVasculitis & PMR
Rheumatology (Oxford)
Rheumatology (Oxford)
Prevalence of ultrasound and clinical findings suggestive of inflammatory arthritis in children with skin psoriasis
Cross-sectional studyPediatric
Rheumatology (Oxford)
Rheumatology (Oxford)
Non-invasive imaging and clinical skin scores in juvenile localized scleroderma
Cohort studyPediatric
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Apical fibrobullous lung disease in spondyloarthritis patients with biologic DMARDs indication
Cohort studySpondyloarthritis & PsA
Rheumatology (Oxford)
Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study
Cross-sectional studyAcross diseases
Rheumatology (Oxford)
Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud’s Phenomenon (ASRAP) questionnaire
Diagnostic or prognostic studySystemic sclerosis
Rheumatology (Oxford)
Increased risk of cardiovascular disease preceding diagnosis of incident ANCA-associated vasculitis: a Danish nationwide study
Case-control studyVasculitis & PMR
Rheumatology (Oxford)
Rheumatology (Oxford)
Pyrin variant E148Q potentiates inflammasome activation and the effect of pathogenic mutations in cis
Mechanistic studyAutoinflammatory & rare
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis
Randomized controlled trialAutoinflammatory & rare
Rheumatology (Oxford)
Autoimmune diseases exhibit shared alterations in the gut microbiota
Meta-analysisAcross diseases
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
Rheumatology (Oxford)
The SLE-DAS provides an accurate and feasible flare tool in the clinical setting: a validation study
Diagnostic or prognostic studyLupus & APS
Rheumatology (Oxford)
Rheumatology (Oxford)